Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 2, 2005, Pages 354-361

  Milano, Michael T ^a   Jani, Ashesh B ^a   Farrey, Karl J ^a   Rash, Carla ^a   Heimann, Ruth ^b   Chmura, Steven J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Anal cancer; Chemoradiation; Intensity modulated radiation therapy

Indexed keywords

BONE; DOSIMETRY; ONCOLOGY; PATIENT MONITORING; TOXICITY; TUMORS;

ANAL CANCER; CHEMORADIATION; INTENSITY MODULATED RADIATION THERAPY; SQUAMOUS CELL CARCINOMA;

RADIOTHERAPY;

FLUOROURACIL; MITOMYCIN C;

ACUTE TOXICITY; ADULT; AGED; ANUS CARCINOMA; ANUS DISEASE; ARTICLE; BLADDER DISEASE; BLOOD CELL COUNT; BLOOD TOXICITY; BONE MARROW; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLOSTOMY; CONTROLLED STUDY; DEHYDRATION; DERMATITIS; DESQUAMATION; DIARRHEA; DRUG TOLERABILITY; ERYTHROCYTE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GENITAL SYSTEM DISEASE; GLUTEUS MAXIMUS MUSCLE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOCYTE; LUNG EMBOLISM; MALE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; NEUTROPENIA; NEUTROPHIL; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; SIDE EFFECT; SKIN TOXICITY; SMALL INTESTINE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24944455909     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.02.030     Document Type: Article

References (40)

1. Intensity Modulated Radiation Therapy Collaborative Working Group Intensity-modulated radiotherapy Current status and issues of interest Int J Radiat Oncol Biol Phys 51 2001 880 914
2. A.J. Mundt, J.C. Roeske, A.E. Lujan Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies Gynecol Oncol 82 2001 456 463
3. C.J. Brixey, J.C. Roeske, A.E. Lujan Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 54 2002 1388 1396
4. A.J. Mundt, A.E. Lujan, J. Rotmensch Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 2002 1330 1337
5. A.E. Lujan, A.J. Mundt, S.D. Yamada Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy Int J Radiat Oncol Biol Phys 57 2003 516 521
6. A.J. Mundt, L.K. Mell, J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int J Radiat Oncol Biol Phys 56 2003 1354 1360
7. A.B. Jani Organ motion and IMRT in prostate cancer therapy Cancer J 9 2003 244 246
8. A.B. Jani, J.C. Roeske, C. Rash Intensity-modulated radiation therapy for prostate cancer Clin Prostate Cancer 2 2003 98 105
9. J. Kao, J. Turian, A. Meyers Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer Br J Radiol 77 2004 129 136
10. M.T. Milano, E.E. Vokes, M.E. Witt Retrospective comparison of intensity modulated radiation therapy (IMRT) and conventional three-dimensional RT (3DCRT) in advanced head and neck patients treated with definitive chemoradiation [Abstract] Proc Am Soc Clin Oncol 22 2003 499
11. M.T. Milano, S.J. Chmura, M.C. Garofalo Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies toxicity and clinical outcome Int J Radiat Oncol Biol Phys 59 2004 445 453
12. International Commission on Radiation Units and Measurements Report no. 50. Prescribing, recording and reporting photon beam therapy 1993 ICRU Washington, DC
13. G.T. Chen, S.B. Jiang, J. Kung Abdominal organ motion and deformation Implications for IMRT [Abstract] Int J Radiat Oncol Biol Phys 51 2001 210
14. T.S. Lawrence, M.L. Kessler, R.K. Ten Haken Clinical interpretation of dose-volume histograms The basis for normal tissue preservation and tumor dose escalation Front Radiat Ther Oncol 29 1996 57 66
15. M. John, T. Pajak, M. Flam Dose escalation in chemoradiation for anal cancer Preliminary results of RTOG 92-08 Cancer J Sci Am 2 1996 205
16. E.C. Constantinou, W. Daly, C.Y. Fung Time-dose considerations in the treatment of anal cancer Int J Radiat Oncol Biol Phys 39 1997 651 657
17. J.A. Martenson, S.R. Lipsitz, H. Wagner Jr Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292) An Eastern Cooperative Oncology Group study Int J Radiat Oncol Biol Phys 35 1996 745 749
18. M. Flam, M. John, T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal Results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539
19. S.L. Sailer, E.L. Chaney, J.G. Rosenman Three dimensional treatment planning at the University of North Carolina at Chapel Hill Semin Radiat Oncol 2 1992 267 273
20. A. Trotti, R. Byhardt, J. Stetz Common toxicity criteria: Version 2.0: An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
21. N.D. Nigro, V.K. Vaitkevicius, B. Considine Jr Combined therapy for cancer of the anal canal A preliminary report Dis Colon Rectum 17 1974 354 356
22. N.D. Nigro, V.K. Vaitkevicius, T. Buroker Combined therapy for cancer of the anal canal Dis Colon Rectum 24 1981 73 75
23. N.D. Nigro, H.G. Seydel, B. Considine Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal Cancer 51 1983 1826 1829
24. B.J. Cummings, A.R. Harwood, T.J. Keane Combined treatment of squamous cell carcinoma of the anal canal Radical radiation therapy with 5-fluorouracil and mitomycin-C, a preliminary report Dis Colon Rectum 23 1980 389 391
25. B. Cummings, T. Keane, G. Thomas Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy Cancer 54 1984 2062 2068
26. B.J. Cummings, T.J. Keane, B. O'Sullivan Epidermoid anal cancer Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C Int J Radiat Oncol Biol Phys 21 1991 1115 1125
27. B. Sischy The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum Int J Radiat Oncol Biol Phys 11 1985 1587 1593
28. L.L. Hughes, T.A. Rich, L. Delclos Radiotherapy for anal cancer Experience from 1979-1987 Int J Radiat Oncol Biol Phys 17 1989 1153 1160
29. R.J. Myerson, S.J. Shapiro, D. Lacey Carcinoma of the anal canal Am J Clin Oncol 18 1995 32 39
30. R.J. Myerson, F. Kong, E.H. Birnbaum Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome Radiother Oncol 61 2001 15 22
31. B. Sischy, R.L. Doggett, J.M. Krall Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma Interim report on Radiation Therapy Oncology Group study no 8314. J Natl Cancer Inst 81 1989 850 856
32. H. Bartelink, F. Roelofsen, F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049
33. UKCCR Anal Cancer Trial Working Party Epidermoid anal cancer Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1996 1049 1054
34. T.A. Rich, J.A. Ajani, W.H. Morrison Chemoradiation therapy for anal cancer Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin Radiother Oncol 27 1993 209 215
35. J.F. Bosset, F. Roelofsen, D.A. Morgan Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups Eur J Cancer 39 2003 45 51
36. J.A. Martenson, S.R. Lipsitz, M. Lefkopoulou Results of combined modality therapy for patients with anal cancer (E7283) An Eastern Cooperative Oncology Group study Cancer 76 1995 1731 1736
37. R. Doci, R. Zucali, G. La Monica Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus Results in 35 consecutive patients J Clin Oncol 14 1996 3121 3125
38. D. Peiffert, M. Giovannini, M. Ducreux High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer Final results of a phase II study Ann Oncol 12 2001 397 404
39. A. Hung, C. Crane, M. Delclos Cisplatin-based combined modality therapy for anal carcinoma A wider therapeutic index Cancer 97 2003 1195 1202
40. D. Peiffert [Rationale and progress of the phase III trial Intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal Cancer Radiother 7 Suppl. 1 2003 100s 107s